Journal of Market Access & Health Policy
Volume 8, 2020 - Issue 1
Open access
2,362
Views
17
CrossRef citations to date
0
Altmetric
Guideline
Health economic evaluation of gene replacement therapies: methodological issues and recommendations
Samuel Aballéaa Creativ-Ceutical, HEOR, Rotterdam, NetherlandsCorrespondence[email protected]
View further author information
, View further author information
Katia Thokagevistkb Creativ-Ceutical, HEOR, Paris, FranceView further author information
, Rimma Velikanovac Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen, NetherlandsView further author information
, Steven Simoensd Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, BelgiumView further author information
, Lieven Annemanse Department of Public Health, Ghent University, Ghent, BelgiumView further author information
, Fernando Antonanzasf Department of Economics, University of La Rioja, Logroño, SpainView further author information
, Pascal Auquierg CEReSS - Health Service Research and Quality of Life Center, Aix-Marseille University, Marseille, FranceView further author information
, Clément Françoisb Creativ-Ceutical, HEOR, Paris, France;h Public Health Department - Research Unit, Aix-Marseille University, Marseille, FranceView further author information
, Frank-Ulrich Frickei Technische Hochschule Nürnberg, Nürnberg, GermanyView further author information
, Daniel Malonej Pharmacotherapy Faculty, College of Pharmacy, University of Utah, Salt Lake City, USAView further author information
, Aurélie Millierb Creativ-Ceutical, HEOR, Paris, FranceView further author information
, Ulf Perssonk The Swedish Institute for Health Economics (IHE), Lund, SwedenView further author information
, Stavros Petroul Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UKView further author information
, Omar Dabbousm Global Health Economics and Outcomes Research and Real World EvidenceAveXis Inc, Novartis Gene Therapies, Bannockburn, IL, USAView further author information
, Maarten Postmac Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology & Economics, University of Groningen, Groningen, Netherlandshttps://orcid.org/0000-0002-6306-3653View further author information
& Mondher Toumib Creativ-Ceutical, HEOR, Paris, France;h Public Health Department - Research Unit, Aix-Marseille University, Marseille, Francehttps://orcid.org/0000-0001-7939-7204View further author information
show all
Article: 1822666
|
Received 20 Mar 2020, Accepted 04 Sep 2020, Published online: 11 Oct 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.